Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Hélène E. Aschmann"'
Autor:
Dominik Menges, Kyra D. Zens, Tala Ballouz, Nicole Caduff, Daniel Llanas-Cornejo, Hélène E. Aschmann, Anja Domenghino, Céline Pellaton, Matthieu Perreau, Craig Fenwick, Giuseppe Pantaleo, Christian R. Kahlert, Christian Münz, Milo A. Puhan, Jan S. Fehr
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
The persistence of the immune response to SARS-CoV-2 after recovery from infection is an indicator for subsequent protection against infection. Here the authors follow recovered patients and measure antibody and T cell responses and find that these t
Externí odkaz:
https://doaj.org/article/3c413cd38d774f3f8eeea4ab88b32e21
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background We previously showed that the 10-year cardiovascular disease (CVD) risk threshold to initiate statins for primary prevention depends on the baseline CVD risk, age, sex, and the incidence of statin-related harm outcome and competin
Externí odkaz:
https://doaj.org/article/51eaac92992f4bfd80b2791c30d35527
Autor:
Anja Domenghino, Hélène E. Aschmann, Tala Ballouz, Dominik Menges, Dominique Strebel, Sandra Derfler, Jan S. Fehr, Milo A. Puhan
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Background Isolation is an indispensable measure to contain the SARS-CoV-2 virus, but it may have a negative impact on mental health and overall wellbeing. Evidence on the isolation experience, facilitating and complicating factors is needed to mitig
Externí odkaz:
https://doaj.org/article/b944f3a00d234b0eba8fa9c0230c3499
Autor:
Hélène E. Aschmann, Milo A. Puhan, Craig W. Robbins, Elizabeth A. Bayliss, Wiley V. Chan, Richard A. Mularski, Renée F. Wilson, Wendy L. Bennett, Orla C. Sheehan, Tsung Yu, Henock G. Yebyo, Bruce Leff, Heather Tabano, Karen Armacost, Carol Glover, Katie Maslow, Suzanne Mintz, Cynthia M. Boyd
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-9 (2019)
Abstract Background Older people with hypertension and multiple chronic conditions (MCC) receive complex treatments and face challenging trade-offs. Patients’ preferences for different health outcomes can impact multiple treatment decisions. Since
Externí odkaz:
https://doaj.org/article/1e624d606fab47e4b2034bff6a9ea704
Autor:
Tala Ballouz, Dominik Menges, Hélène E. Aschmann, Anja Domenghino, Jan S. Fehr, Milo A. Puhan, Viktor von Wyl
Publikováno v:
International Journal of Public Health, Vol 66 (2021)
Objectives: We aimed to evaluate the effectiveness of the SwissCovid digital proximity tracing (DPT) app in notifying exposed individuals and prompting them to quarantine earlier compared to individuals notified only by manual contact tracing (MCT).M
Externí odkaz:
https://doaj.org/article/b1e04ce3b3824502932e438168f5af7e
Publikováno v:
BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Patient preferences are key parameters to evaluate benefit-harm balance of statins for primary prevention but they are not readily available to guideline developers and decision makers. Our study aimed to elicit patient preference
Externí odkaz:
https://doaj.org/article/f077e92e49d2462882089d2ec68f63c4
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Background: We determined the risk thresholds above which statin use would be more likely to provide a net benefit for people over the age of 75 years without history of cardiovascular disease (CVD). Methods: An exponential model was used to estimate
Externí odkaz:
https://doaj.org/article/7ad51a813e2147ec897be1a7373471fd
Autor:
Allan Musinguzi, Joan R Kasidi, Jillian L Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T Kunihira, Bishop Opira, Yeonsoo Baik, Devika Patel, Amanda Sammann, Christopher A Berger, Hélène E Aschmann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick P J Phillips, Noah Kiwanuka, Achilles Katamba, David W Dowdy, Adithya Cattamanchi, Fred C Semitala, Anne R Katahoire
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 10, p e0003347 (2024)
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify factors influencing successful 3HP deliv
Externí odkaz:
https://doaj.org/article/41e77009facc4c0783714fa4d40e15f8
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282658 (2023)
Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). Eventually, patients may consider whether to stop ASMs, which requires weighing treatment benefit versus
Externí odkaz:
https://doaj.org/article/03b3b796f030449cb34a79e9f5118beb
Autor:
Tala Ballouz, Dominik Menges, Hélène E Aschmann, Ruedi Jung, Anja Domenghino, Jan S Fehr, Milo A Puhan, Viktor von Wyl
Publikováno v:
JMIR Public Health and Surveillance, Vol 8, Iss 5, p e35653 (2022)
BackgroundDigital proximity tracing (DPT) aims to complement manual contact tracing (MCT) in identifying exposed contacts and preventing further transmission of SARS-CoV-2 in the population. Although several DPT apps, including SwissCovid, have shown
Externí odkaz:
https://doaj.org/article/070c50b47d6b40b0bc3d923a25495be5